|

Chiauranib Clinical Trials

2 actively recruiting trials across 1 location

Also known as: CS2164

Pipeline

Phase 3: 1Phase 1/2: 1

Top Sponsors

  • Chipscreen Biosciences, Ltd.2

Indications

  • Cancer2
  • Chiauranib1
  • Relapsed or Refractory1
  • Advanced Solid Malignant Tumor1
  • Paclitaxel1

Other1 trial

Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer
Phase 3

Encinitas, California1 trial

Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.

California Cancer Associates-Encintas

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.